325 related articles for article (PubMed ID: 34676694)
1. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?
Gungor O; Ulu S; Hasbal NB; Anker SD; Kalantar-Zadeh K
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1380-1392. PubMed ID: 34676694
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Dynapenia and Sarcopenia and Their Associations With Serum Insulin-Like Growth Factor-1 Levels in Renal Transplant Recipients.
Yildirim S; Colak T; Bayraktar N; Sezer S
J Ren Nutr; 2022 May; 32(3):354-362. PubMed ID: 34716090
[TBL] [Abstract][Full Text] [Related]
3. Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review.
Noor H; Reid J; Slee A
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1621-1640. PubMed ID: 34585539
[TBL] [Abstract][Full Text] [Related]
4. Kidney function in cachexia and sarcopenia: Facts and numbers.
Okamura M; Konishi M; Butler J; Kalantar-Zadeh K; von Haehling S; Anker SD
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1589-1595. PubMed ID: 37222019
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5.
Zhou Y; Hellberg M; Svensson P; Höglund P; Clyne N
Nephrol Dial Transplant; 2018 Feb; 33(2):342-348. PubMed ID: 28340152
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia in chronic kidney disease: what have we learned so far?
Sabatino A; Cuppari L; Stenvinkel P; Lindholm B; Avesani CM
J Nephrol; 2021 Aug; 34(4):1347-1372. PubMed ID: 32876940
[TBL] [Abstract][Full Text] [Related]
7. Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK Biobank study.
Wilkinson TJ; Miksza J; Yates T; Lightfoot CJ; Baker LA; Watson EL; Zaccardi F; Smith AC
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):586-598. PubMed ID: 33949807
[TBL] [Abstract][Full Text] [Related]
8. Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.
Heitman K; Alexander MS; Faul C
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791164
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Stage of Chronic Kidney Disease and Sarcopenia in Korean Aged 40 Years and Older Using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008-2011.
Moon SJ; Kim TH; Yoon SY; Chung JH; Hwang HJ
PLoS One; 2015; 10(6):e0130740. PubMed ID: 26083479
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia in chronic kidney disease.
Souza VA; Oliveira Dd; Mansur HN; Fernandes NM; Bastos MG
J Bras Nefrol; 2015; 37(1):98-105. PubMed ID: 25923756
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality.
Pereira RA; Cordeiro AC; Avesani CM; Carrero JJ; Lindholm B; Amparo FC; Amodeo C; Cuppari L; Kamimura MA
Nephrol Dial Transplant; 2015 Oct; 30(10):1718-25. PubMed ID: 25999376
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis.
Duarte MP; Almeida LS; Neri SGR; Oliveira JS; Wilkinson TJ; Ribeiro HS; Lima RM
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):501-512. PubMed ID: 38263952
[TBL] [Abstract][Full Text] [Related]
13. Identification of sarcopenia and dynapenia in CKD predialysis patients with EGWSOP2 criteria: An observational, cross-sectional study.
Guida B; Maro MD; Lauro MD; Lauro TD; Trio R; Santillo M; Belfiore A; Memoli A; Cataldi M
Nutrition; 2020 Oct; 78():110815. PubMed ID: 32480255
[TBL] [Abstract][Full Text] [Related]
14. Advanced oxidation protein products contribute to chronic kidney disease-induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway.
Kato H; Watanabe H; Imafuku T; Arimura N; Fujita I; Noguchi I; Tanaka S; Nakano T; Tokumaru K; Enoki Y; Maeda H; Hino S; Tanaka M; Matsushita K; Fukagawa M; Maruyama T
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1832-1847. PubMed ID: 34599649
[TBL] [Abstract][Full Text] [Related]
15. Screening for muscle wasting and dysfunction in patients with chronic kidney disease.
Carrero JJ; Johansen KL; Lindholm B; Stenvinkel P; Cuppari L; Avesani CM
Kidney Int; 2016 Jul; 90(1):53-66. PubMed ID: 27157695
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Correlates of Sarcopenia among Elderly CKD Outpatients on Tertiary Care.
D'Alessandro C; Piccoli GB; Barsotti M; Tassi S; Giannese D; Morganti R; Cupisti A
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30544657
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of sarcopenia in chronic kidney disease.
Moorthi RN; Avin KG
Curr Opin Nephrol Hypertens; 2017 May; 26(3):219-228. PubMed ID: 28198733
[TBL] [Abstract][Full Text] [Related]
18. Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know?
Massini G; Caldiroli L; Molinari P; Carminati FMI; Castellano G; Vettoretti S
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513525
[TBL] [Abstract][Full Text] [Related]
19. Uraemic sarcopenia: aetiology and implications.
Fahal IH
Nephrol Dial Transplant; 2014 Sep; 29(9):1655-65. PubMed ID: 23625972
[TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
Enoki Y; Watanabe H; Arake R; Fujimura R; Ishiodori K; Imafuku T; Nishida K; Sugimoto R; Nagao S; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):735-747. PubMed ID: 28608457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
